Role of definitive radiotherapy in treating patients with inoperable Merkel cell carcinoma: the Westmead Hospital experience and a review of the literature

The Australasian Journal of Dermatology
Clare S L Koh, Michael Veness

Abstract

Merkel cell carcinoma (MCC) is an uncommon aggressive primary cutaneous neuroendocrine carcinoma with a propensity to spread to regional lymph nodes and distant sites. The head and neck is the commonest site for presentation (50-60%) and recent evidence suggests patients treated with excision (to achieve a negative microscopic margin) and adjuvant wide-field radiotherapy (RTx) have an improved survival compared with surgery alone. Surgery is often not possible in elderly patients with multiple co-morbidities and in patients with advanced lesions. Definitive RTx therefore remains an option in these inoperable patients, with data to report its benefit. We report the results of eight patients with inoperable MCC treated with RTx alone between 1993 and 2007 at Westmead Hospital, Sydney, Australia, and also review the relevant literature on definitive RTx in the treatment of MCC. The median age at diagnosis was 82.5 years in five women and three men. All patients were Caucasian and none were immunosuppressed. Seven of eight patients were clinically node-positive. The mean duration of follow up was 12 months. A median dose of 50 Gy was prescribed. Seven of eight patients with inoperable MCC achieved in-field control, with most eventu...Continue Reading

References

Mar 1, 1991·Clinical Oncology : a Journal of the Royal College of Radiologists·H Hasle
Mar 1, 1991·Clinical Oncology : a Journal of the Royal College of Radiologists·J D BrierleyA Y Rostom
Sep 1, 1990·International Journal of Radiation Oncology, Biology, Physics·W H MorrisonH Goepfert
Dec 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S PilottiA Grisotti
Jan 1, 1972·Archives of Dermatology·C Toker
Aug 1, 1981·Annals of Plastic Surgery·E Elliott
Mar 1, 1995·Head & Neck·M SuntharalingamR R Million
Jul 30, 1995·International Journal of Radiation Oncology, Biology, Physics·J H LeonardG W Birrell
Apr 1, 1997·The British Journal of Dermatology·S K al-Ghazal, A Hong
Jan 1, 1997·Clinical Oncology : a Journal of the Royal College of Radiologists·P SavageM E Gore
Nov 20, 1998·Radiation Oncology Investigations·R M NathuJ T Parsons
Apr 13, 1999·Archives of Surgery·M J OttW W Souba
Apr 21, 2001·Annals of Surgical Oncology·H Medina-FrancoS W Beenken
Feb 2, 2002·American Journal of Clinical Oncology·Hans Theodor EichRolf-Peter Müller
Nov 1, 2002·Head & Neck·Anthony E BrissettScott E Strome
Dec 17, 2003·Archives of Dermatology·Laurent MortierEric Lartigau
Jun 4, 2005·ANZ Journal of Surgery·Michael J VenessVal Gebski
Sep 2, 2005·Cancer·William J McAfeeWilliam M Mendenhall
Jun 21, 2006·Archives of Dermatology·Kevan G LewisClark C Otley
Jul 27, 2006·The Australasian Journal of Dermatology·Michael J Veness
Feb 3, 2007·Seminars in Oncology·Michael Howard Swann, Jaeyoung Yoon
Mar 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pablo MojicaJoshua D I Ellenhorn
Mar 11, 2008·Current Opinion in Otolaryngology & Head and Neck Surgery·Michael J VenessGary J Morgan
Aug 19, 2008·International Journal of Radiation Oncology, Biology, Physics·Michael PoulsenDanny Rischin

❮ Previous
Next ❯

Citations

May 22, 2013·Journal of Skin Cancer·Inamaria Erovic, Boban M Erovic
Jul 9, 2014·Annals of Surgical Oncology·Chris Harrington, Winkle Kwan
Nov 3, 2012·Hematology/oncology Clinics of North America·Sandra Y HanSiegrid S Yu
Apr 10, 2012·Seminars in Oncology·Sreekanth DonepudiWolfram E Samlowski
Nov 27, 2009·International Journal of Radiation Oncology, Biology, Physics·Michael VenessMichael Poulsen
Jun 6, 2013·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Jürgen C BeckerStephan Grabbe
Feb 1, 2013·Journal of Skin Cancer·G MorandG F Huber
Dec 12, 2012·The Journal of Dermatological Treatment·Rafal MatkowskiBartlomiej Szynglarewicz
Jun 8, 2014·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Alexandra FochtmannBoban M Erovic
Oct 6, 2017·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·A Fochtmann-FranaB M Erovic
Aug 1, 2011·Expert Review of Dermatology·Zoe RushIsaac Brownell
Aug 7, 2020·Asia-Pacific Journal of Clinical Oncology·David L KokGerald Fogarty
Aug 31, 2019·Dermatologic Clinics·Drew A Emge, Adela R Cardones

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
R Salvador AlonsoR de Crevoisier
© 2022 Meta ULC. All rights reserved